Baxter International Inc

US

BAX

Health Care

40.4 ₽

Current price

Sell
40.4 ₽

Target price 00%

Ranks rating

76

  • Position in sub-industry

    422 / 663

  • Position in country

    10209 / 14179

  • Return on Assets, %

    -0.3

    -11.9

  • Net income margin, %

    1.8

    -12.5

  • EBITDA margin, %

    20

    -2.5

  • Debt to Equity, %

    164.2

    15

  • Intangible assets and goodwill, %

    44.5

    3.9

  • Revenue CAGR 3Y, %

    8.2

    12.6

  • Total Equity change 1Y, %

    44

    0

  • Revenue Y, % chg

    2.1

    4.6

  • P/BV

    2.4

    1.7

  • P/S

    1.3

    3.7

  • EV/S

    2.1

    3.2

  • EV/EBITDA

    10.9

    -0.2

  • Average Analyst recommendation

    Hold

    Hold

  • Average upside forecasts, %

    10.3

    66.5

  • Forward P/E

    13.4

    19.2

  • Dividend Yield, %

    2.8

    1.8

  • Forward Dividend Yield, %

    3.1

    0.2

  • Expected dividend per share

    1.2

    0

  • Dividend Ex Date

    2024-02-29

Get an analytical review of this company

Competitors

Ranks

  • Dexcom Inc

    00%

  • Boston Scientific Corp

    00%

  • Intuitive Surgical Inc

    00%

  • Stryker Corp

    00%

  • Edwards Lifesciences Corp

    00%

  • IDEXX Laboratories Inc

    00%

  • Abbott Laboratories

    00%

  • GE Healthcare Technologies Inc

    00%

  • Baxter International Inc

    00%

  • Becton Dickinson and Co

    00%

Ready-made portfolio of the best Russian stocks

  • Created by artificial intelligence
  • Verified by analysts
  • Available even to beginners

Company information

  • Country

    United States of America

  • Sector

    Health Care

  • Industry group

    Health Care Equipment & Services

  • Industry

    Health Care Equipment & Supplies

  • Sub-sector

    Health Care

  • Capitalization (millions of $)

    20541.9

  • Ticker

    BAX.N

  • ISIN

    US0718131099

  • IPO date

    1961-05-15

  • Availability on Russian exchanges

    Yes

  • Reporting for

    2024-02-08

  • Date fact. publication of reports

    2023-12-31

Company Description

Baxter International Inc., through its subsidiaries, provides a portfolio of essential healthcare products. The Company’s products include renal care, medication delivery, pharmaceuticals, clinical nutrition, advanced surgery and acute therapies. Its renal care offering includes peritoneal dialysis (PD), hemodialysis (HD) and additional dialysis therapies and services. Its medication delivery offerings include intravenous (IV) therapies, infusion pumps, administration sets and drug reconstitution devices. Its pharmaceuticals offerings include premixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services. Its clinical nutrition offerings include parenteral nutrition (PN) therapies and related products. Its advanced surgery offerings include biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention. It also offers polysaccharide hemostatic system (PerClot) products.

A step towards better analytics

  • find the best promotions through the Screener
  • keep an eye on stock valuation
  • download detailed reports

and much more after free registration

Registration

More convenient from your phone? Download: